Advertisement
Research Article Free access | 10.1172/JCI118233
Department of Medicine, East Carolina University School of Medicine, Greenville, North Carolina 27858, USA.
Find articles by de Vente, J. in: JCI | PubMed | Google Scholar
Department of Medicine, East Carolina University School of Medicine, Greenville, North Carolina 27858, USA.
Find articles by Kukoly, C. in: JCI | PubMed | Google Scholar
Department of Medicine, East Carolina University School of Medicine, Greenville, North Carolina 27858, USA.
Find articles by Bryant, W. in: JCI | PubMed | Google Scholar
Department of Medicine, East Carolina University School of Medicine, Greenville, North Carolina 27858, USA.
Find articles by Posekany, K. in: JCI | PubMed | Google Scholar
Department of Medicine, East Carolina University School of Medicine, Greenville, North Carolina 27858, USA.
Find articles by Chen, J. in: JCI | PubMed | Google Scholar
Department of Medicine, East Carolina University School of Medicine, Greenville, North Carolina 27858, USA.
Find articles by Fletcher, D. in: JCI | PubMed | Google Scholar
Department of Medicine, East Carolina University School of Medicine, Greenville, North Carolina 27858, USA.
Find articles by Parker, P. in: JCI | PubMed | Google Scholar
Department of Medicine, East Carolina University School of Medicine, Greenville, North Carolina 27858, USA.
Find articles by Pettit, G. in: JCI | PubMed | Google Scholar
Department of Medicine, East Carolina University School of Medicine, Greenville, North Carolina 27858, USA.
Find articles by Lozano, G. in: JCI | PubMed | Google Scholar
Department of Medicine, East Carolina University School of Medicine, Greenville, North Carolina 27858, USA.
Find articles by Cook, P. in: JCI | PubMed | Google Scholar
Published October 1, 1995 - More info
Protein kinase C (PKC) modulates growth, differentiation and apoptosis in a cell-specific fashion. Overexpression of PKC-alpha in MCF-7 breast cancer cells (MCF-7-PKC-alpha cell) leads to expression of a more transformed phenotype. The response of MCF-7 and MCF-7-PKC-alpha cells to phorbol esters (TPA) was examined. TPA-treated MCF-7 cells demonstrated a modest cytostatic response associated with a G1 arrest that was accompanied by Cip1 expression and retinoblastoma hypophosphorylation. While p53 was detected in MCF-7 cells, evidence for TPA-induced stimulation of p53 transcriptional activity was not evident. In contrast, TPA treatment induced death of MCF-7-PKC-alpha cells. Bryostatin 1, another PKC activator, exerted modest cytostatic effects on MCF-7 cells while producing a cytotoxic response at low doses in MCF-7-PKC-alpha cells that waned at higher concentrations. TPA-treated MCF-7-PKC-alpha cells accumulated in G2/M, did not express p53, displayed decreased Cip1 expression, and demonstrated a reduction in retinoblastoma hypophosphorylation. TPA-treated MCF-7-PKC-alpha cells expressed gadd-45 which occurred before the onset of apoptosis. Thus, alterations in the PKC pathway can modulate the decision of a breast cancer cell to undergo death or differentiation. In addition, these data show that PKC activation can induce expression of gadd45 in a p53-independent fashion.
Images.